MCID: PRC016
MIFTS: 61

Pre-Eclampsia

Categories: Blood diseases, Cardiovascular diseases, Nephrological diseases, Rare diseases, Reproductive diseases, Respiratory diseases

Aliases & Classifications for Pre-Eclampsia

MalaCards integrated aliases for Pre-Eclampsia:

Name: Pre-Eclampsia 12 26 45 15 74
Preeclampsia 12 77 26 60 30 56 6 17
Pregnancy Associated Hypertension 12 74
Gestational Hypertension 12 15
Hypertension, Pregnancy-Induced, Susceptibility to 6
Proteinuric Hypertension of Pregnancy 12
Gestational Proteinuric Hypertension 26
Transient Hypertension of Pregnancy 74
Hypertension Induced by Pregnancy 12
Preeclampsia, Susceptibility to 6
Pregnancy-Induced Hypertension 26
Pre-Eclamptic Toxaemia 12
Preeclampsia/eclampsia 12
Toxaemia of Pregnancy 12
Toxemia of Pregnancy 26
Pregnancy Toxemias 56
Pregnancy Toxemia 12

Classifications:



External Ids:

Disease Ontology 12 DOID:10591
MeSH 45 D011225
ICD10 via Orphanet 35 O14.0 O14.1 O14.2 more
UMLS via Orphanet 75 C0032914
Orphanet 60 ORPHA275555

Summaries for Pre-Eclampsia

Genetics Home Reference : 26 Preeclampsia is a complication of pregnancy in which affected women develop high blood pressure (hypertension); they can also have abnormally high levels of protein in their urine (proteinuria). This condition usually occurs in the last few months of pregnancy and often requires early delivery of the infant. However, this condition can also appear shortly after giving birth (postpartum preeclampsia).

MalaCards based summary : Pre-Eclampsia, also known as preeclampsia, is related to mild pre-eclampsia and eclampsia, and has symptoms including edema, hyperemesis gravidarum and morning sickness. An important gene associated with Pre-Eclampsia is NSD1 (Nuclear Receptor Binding SET Domain Protein 1), and among its related pathways/superpathways are Signaling events mediated by VEGFR1 and VEGFR2 and Glypican 1 network. The drugs Methyldopa and Calcium Carbonate have been mentioned in the context of this disorder. Affiliated tissues include placenta, endothelial and testes.

Disease Ontology : 12 A hypertension occurring during pregnancy characterized by large amounts of protein in the urine (proteinuria) and edema, usually by the last trimester of pregnancy.

Wikipedia : 77 Pre-eclampsia (PE) is a disorder of pregnancy characterized by the onset of high blood pressure and... more...

Related Diseases for Pre-Eclampsia

Diseases in the Eclampsia family:

Pre-Eclampsia Severe Pre-Eclampsia

Diseases related to Pre-Eclampsia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 410)
# Related Disease Score Top Affiliating Genes
1 mild pre-eclampsia 35.1 FLT1 PGF
2 eclampsia 34.2 CORIN FLT1 PEE1 PGF SERPINC1 STOX1
3 hellp syndrome 33.4 FLT1 PGF SERPINC1
4 preeclampsia/eclampsia 1 32.9 NSD1 PEE1
5 placental abruption 31.5 FLT1 PGF SERPINC1
6 microvascular complications of diabetes 5 30.7 FLT1 NOS3 PGF
7 arteries, anomalies of 30.7 FLT1 NOS3 PGF SERPINC1
8 homocysteinemia 30.6 H19 NOS3 SERPINC1
9 coronary heart disease 1 30.3 H19 NOS3 WFDC21P
10 placenta accreta 30.1 FLT1 PGF
11 atherosclerosis susceptibility 30.1 H19 NOS3 TUG1
12 renal cell carcinoma, nonpapillary 29.6 FLT1 H19 HOTAIR MALAT1 TUG1
13 melanoma 29.4 H19 HOTAIR MALAT1 SPRY4-IT1 WFDC21P
14 pancreatic cancer 28.6 H19 HOTAIR MALAT1 SPRY4-IT1 TUG1
15 severe pre-eclampsia 13.0
16 preeclampsia/eclampsia 4 12.2
17 preeclampsia/eclampsia 5 12.2
18 preeclampsia/eclampsia 2 12.1
19 preeclampsia/eclampsia 3 12.1
20 gestational diabetes 11.7
21 epithelioid hemangioendothelioma 10.6 FLT1 PGF
22 twin-to-twin transfusion syndrome 10.5 FLT1 PGF
23 hypoxia 10.5
24 cancer-associated retinopathy 10.5 FLT1 PGF
25 polymorphic reticulosis 10.5
26 diabetes mellitus 10.5
27 retinal vascular occlusion 10.4 PGF SERPINC1
28 familial hypertension 10.4
29 postpartum psychosis 10.4
30 antiphospholipid syndrome 10.4
31 gastric cardia adenocarcinoma 10.3 H19 HOTAIR
32 diabetes mellitus, noninsulin-dependent 10.3
33 hydatidiform mole, recurrent, 1 10.3
34 body mass index quantitative trait locus 1 10.3
35 thrombophilia 10.3
36 gestational trophoblastic neoplasm 10.3
37 periodontal disease 10.3
38 placental insufficiency 10.3
39 rere-related disorders 10.3
40 hypertension, essential 10.3
41 kidney disease 10.3
42 encephalopathy 10.3
43 placenta praevia 10.2
44 neonatal jaundice 10.2
45 breast cancer 10.2
46 systemic lupus erythematosus 10.2
47 retinal detachment 10.2
48 peripartum cardiomyopathy 10.2
49 chronic kidney failure 10.2
50 patau syndrome 10.2

Graphical network of the top 20 diseases related to Pre-Eclampsia:



Diseases related to Pre-Eclampsia

Symptoms & Phenotypes for Pre-Eclampsia

UMLS symptoms related to Pre-Eclampsia:


edema, hyperemesis gravidarum, morning sickness

Drugs & Therapeutics for Pre-Eclampsia

Drugs for Pre-Eclampsia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 454)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Methyldopa Approved Phase 4,Phase 2,Phase 1,Not Applicable 555-30-6 38853
2
Calcium Carbonate Approved, Investigational Phase 4,Phase 3,Not Applicable 471-34-1
3
Remifentanil Approved Phase 4,Phase 2,Phase 1 132875-61-7 60815
4
Sodium Citrate Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 68-04-2
5
Metformin Approved Phase 4,Phase 2,Phase 3,Not Applicable 657-24-9 14219 4091
6
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 50-78-2 2244
7
Enoxaparin Approved Phase 4,Phase 3,Phase 2,Not Applicable 9005-49-6 772
8
tannic acid Approved Phase 4,Phase 3,Not Applicable 1401-55-4
9
Benzocaine Approved, Investigational Phase 4,Phase 3,Not Applicable 94-09-7, 1994-09-7 2337
10
Heparin Approved, Investigational Phase 4,Phase 2,Phase 3,Early Phase 1 9005-49-6 772 46507594
11
Dalteparin Approved Phase 4,Phase 2,Phase 3,Early Phase 1 9005-49-6
12
leucovorin Approved Phase 4,Phase 3,Phase 2,Not Applicable 58-05-9 6006 143
13
Oxytocin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1 50-56-6 439302 53477758
14
Zinc Approved, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 7440-66-6 32051
15
Ephedrine Approved Phase 4,Phase 3,Phase 2,Not Applicable 299-42-3 9294
16
Phenylephrine Approved Phase 4,Not Applicable 59-42-7 6041
17
Oxymetazoline Approved, Investigational Phase 4,Not Applicable 1491-59-4 4636
18
Pseudoephedrine Approved Phase 4,Phase 3,Phase 2,Not Applicable 90-82-4 7028
19
Misoprostol Approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 59122-46-2 5282381
20
Levobupivacaine Approved, Investigational Phase 4 27262-47-1 92253
21
Magnesium Sulfate Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 7487-88-9 24083
22
Furosemide Approved, Vet_approved Phase 4,Phase 2 54-31-9 3440
23
Captopril Approved Phase 4 62571-86-2 44093
24
Clonidine Approved Phase 4,Phase 1,Phase 2,Not Applicable 4205-90-7 2803
25
Acetaminophen Approved Phase 4,Phase 2,Phase 3,Not Applicable 103-90-2 1983
26
Ibuprofen Approved Phase 4,Phase 2,Phase 3,Not Applicable 15687-27-1 3672
27
Rocuronium Approved Phase 4 119302-91-9, 143558-00-3 441290
28
Nifedipine Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 21829-25-4 4485
29
Labetalol Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable 36894-69-6 3869
30
Insulin Lispro Approved Phase 4,Not Applicable 133107-64-9
31
Insulin Aspart Approved Phase 4,Phase 3,Not Applicable 116094-23-6 16132418
32
Glyburide Approved Phase 4,Not Applicable 10238-21-8 3488
33
Amlodipine Approved Phase 4 88150-42-9 2162
34
Azithromycin Approved Phase 4,Phase 3,Not Applicable 83905-01-5 55185 447043
35
Ketorolac Approved Phase 4 66635-83-4, 74103-06-3 3826
36
Warfarin Approved Phase 4 81-81-2 6691 54678486
37
Insulin Detemir Approved Phase 4,Phase 3,Not Applicable 169148-63-4 5311023
38
Etonogestrel Approved, Investigational Phase 4 54048-10-1 40976 6917715
39
Desogestrel Approved Phase 4 54024-22-5 40973
40
Calcium Approved, Nutraceutical Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 7440-70-2 271
41
Citric Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 77-92-9 311
42
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 59-30-3 6037
43
Vitamin D Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 1406-16-2
44
Vitamin D3 Approved, Nutraceutical Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 67-97-0 5280795 6221
45
Ergocalciferol Approved, Nutraceutical Phase 4,Phase 1,Phase 2,Not Applicable 50-14-6 5280793
46
Serine Approved, Nutraceutical Phase 4,Phase 3,Early Phase 1,Not Applicable 56-45-1 5951
47 Antihypertensive Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
48 Calcium, Dietary Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
49 Hormones Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
50 Bone Density Conservation Agents Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable

Interventional clinical trials:

(show top 50) (show all 816)
# Name Status NCT ID Phase Drugs
1 Anti-Hypertensive Treatment In Stable Pregnant Women With Severe Pre-Eclampsia (Metildopape) Unknown status NCT01361425 Phase 4 methildopa;placebo
2 Low Dose Calcium to Prevent Preeclampsia Unknown status NCT02338687 Phase 4
3 Cardiovascular and Autonomic Reactivity in Women With a History of Pre-eclampsia Unknown status NCT00117546 Phase 4 alpha methyldopa
4 Remifentanil for General Anesthesia in Preeclamptics Unknown status NCT00567957 Phase 4 Remifentanil;Saline
5 Viagra for the Treatment of IUGR Unknown status NCT00347867 Phase 4 Viagra administration in IUGR/PET pregnancies
6 Metformin and Gestational Diabetes in High-risk Patients: a RCTs Unknown status NCT00883259 Phase 4 Metformin
7 Effectiveness of Metformin in Recurrent Miscarriage in a Woman With Hyperinsulinaemia Unknown status NCT01718340 Phase 4 Metformin
8 Prevention of Pre-eclampsia and SGA by Low-Dose Aspirin in Nulliparous Women With Abnormal First-trimester Uterine Artery Dopplers Completed NCT01729468 Phase 4 Aspirin;Placebo
9 Adding MgSO4 to Epidural Levobupivacaine in CS for Patients With Preeclampsia Completed NCT02699827 Phase 4 Levobupivacaine hydrochloride;Magnesium sulphate;Saline 0.9%
10 Treatment Approaches to Preeclampsia Completed NCT01030627 Phase 4
11 Diuretics for Postpartum High Blood Pressure in Preeclampsia Completed NCT02163655 Phase 4 FUROSEMIDE;Placebo
12 Comparison of Doses of Acetylsalicylic Acid in Women With Previous History of Preeclampsia Completed NCT01352234 Phase 4 Acetylsalicylic Acid 160 mg;Acetylsalicylic Acid 80 mg
13 Effectiveness Study of Short Course of Magnesium Sulfate for Severe Preeclamsia Completed NCT01408979 Phase 4 Magnesium sulfate 12 hours;Magnesium sulfate 24 hours
14 Trial of Early Screening Test for Pre-eclampsia and Growth Restriction Completed NCT03674606 Phase 4 Low dose aspirin
15 A Trial Comparing Treatment With the Springfusor Infusion Pump to the IV Magnesium Sulfate Regimen Completed NCT02091401 Phase 4 Magnesium Sulfate
16 Clonidine Versus Captopril for Treatment of Postpartum Very High Blood Pressure Completed NCT01761916 Phase 4 CLONIDINE;CAPTOPRIL
17 The Effect of Ibuprofen on Post-partum Blood Pressure in Women With Hypertensive Disorders of Pregnancy Completed NCT02891174 Phase 4 Ibuprofen;Acetaminophen
18 Effects of Magnesium Sulphate on Sugammadex Reversal of Rocuronium Induced Blockade in Gynaecology Patients Completed NCT01972659 Phase 4 placebo;Magnesium Sulphate;sugammadex
19 Oral Antihypertensive Regimens for Management of Hypertension in Pregnancy Completed NCT01912677 Phase 4 Nifedipine;Labetalol;Methyldopa
20 Enoxaparin in the Prevention of Placental Insufficiency in Pregnant Women Completed NCT03528967 Phase 4 Enoxaparin 40 mg / 0.4 mL Prefilled Syringe;Aspirin 100 mg Oral Tablet, Enteric Coated
21 Low Molecular Weight Heparin in Recurrent Miscarriage With Negative Antiphospholipid Antibodies Completed NCT01608347 Phase 4 LMWH+Folic acid;Folic Acid
22 Oxytocin Regimen to Prevent Atony and Postpartum Hemorrhage During Vaginal Delivery: 3-arm RCT Completed NCT00790062 Phase 4 Oxytocin
23 Timing of Initiation of LMWH Administration in Pregnant Women With APS Completed NCT02326051 Phase 4 Enoxaparin;Enoxaparin
24 Metformin Versus Insulin in Gestational Diabetes Completed NCT01240785 Phase 4 metformin;insulin
25 Efficacy of Corifollitropin Alfa Versus Follitropin Beta in Aged IVF (In-vitro Fertilization) Patients Completed NCT02466204 Phase 4 corifollitropin alfa;Follitropin Beta
26 Treatment of Mild Gestational Diabetes With Glyburide Versus Placebo Completed NCT00744965 Phase 4 Glyburide;Placebo
27 Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Pregnant Women Completed NCT02377349 Phase 4 Saline placebo
28 Pharmacokinetics of Amlodipine Besylate at Delivery and During Lactation Completed NCT02353806 Phase 4 Amlodipine besylate
29 The Effect of Two Aspirin Dosing Strategies for Obese Women at High Risk for Preeclampsia Recruiting NCT03735433 Phase 4 162mg aspirin dose
30 Impact of Antichlamydial Treatment on the Rate of Preeclampsia Recruiting NCT03233880 Phase 4 Azithromycin 1gm
31 Efficacy and Safety of 1 g Vs 2 g Per Hour Intravenous Maintenance Dose of MgSO4 in Women With Severe Pre-eclampsia Recruiting NCT03164304 Phase 4 Magnesium Sulfate
32 Phenylephrine Versus Ephedrine in Pre-eclampsia Recruiting NCT02025426 Phase 4 Phenylephrine;Ephedrine
33 Acute Labetalol Use in Preeclampsia Recruiting NCT03872336 Phase 4 Experimental labetalol dose
34 Early Vascular Adjustments During Hypertensive Pregnancy Recruiting NCT02531490 Phase 4 Labetalol;Nifedipine;Methyldopa
35 Acute Control of Chronic Hypertension Recruiting NCT03877692 Phase 4 Experimental dosing of labetalol
36 Oral Nifedipine Versus Labetalol in Treatment of Postpartum Hypertension Recruiting NCT03449277 Phase 4 Oral Tablet
37 Response to Anti-hypertensives in Pregnant and Postpartum Patients Recruiting NCT03506724 Phase 4 Nifedipine;Labetalol
38 Postpartum NSAIDS and Maternal Hypertension Recruiting NCT03824119 Phase 4 Ibuprofen 600 mg
39 Is Procardia XL 60 mg Q Daily Equivalent to 30 mg XL Given Twice Daily? Recruiting NCT03595982 Phase 4 Procardia XL 30Mg;Procardia XL 60Mg
40 Chronotherapy With Low-dose Aspirin for Primary Prevention Recruiting NCT00725127 Phase 4 aspirin;aspirin
41 A Randomized Control Trial of Vitamin D Prophylaxis in the Prevention of Hypertensive Disorders of Pregnancy Recruiting NCT02920593 Phase 4 Vitamin D3
42 Chronic Hypertension and Pregnancy (CHAP) Project Recruiting NCT02299414 Phase 4 Anti-hypertensive therapy
43 Use of Warfarin After the First Trimester in Pregnant Women With APS Recruiting NCT02303171 Phase 4 Enoxaparin;Warfarin
44 Myo-Inositol- Based Co-treatment in Women With PCOS Undergoing Assisted Reproductive Technology Recruiting NCT03177122 Phase 4 Myo-inositol
45 Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy Recruiting NCT03620890 Phase 4 Neutral Protamine Hagedorn (NPH);Detemir insulin
46 A Comparison of Oral Misoprostol and Vaginal Misoprostol for Cervical Ripening and Induction of Labor Recruiting NCT02777190 Phase 4 Misoprostol
47 Effect of Acetaminophen on Postpartum Blood Pressure Control in Preeclampsia With Severe Features Active, not recruiting NCT02911701 Phase 4 Acetaminophen;Ibuprofen
48 Contraception in Women With Sickle Cell Disease Active, not recruiting NCT02594462 Phase 4 etonogestrel-releasing implant contraceptive
49 Discontinuation of Magnesium Sulfate After Delivery in Women With Severe Preeclampsia. A Randomized Controlled Trial Not yet recruiting NCT03318211 Phase 4 Magnesium Sulfate
50 Metformin for Preeclampsia Prevention in Pregnant Women With Type 1 Diabetes Mellitus Not yet recruiting NCT03570632 Phase 4 Metformin

Search NIH Clinical Center for Pre-Eclampsia

Inferred drug relations via UMLS 74 / NDF-RT 52 :


Cochrane evidence based reviews: pre-eclampsia

Genetic Tests for Pre-Eclampsia

Genetic tests related to Pre-Eclampsia:

# Genetic test Affiliating Genes
1 Preeclampsia 30 NOS3

Anatomical Context for Pre-Eclampsia

MalaCards organs/tissues related to Pre-Eclampsia:

42
Placenta, Endothelial, Testes, Kidney, Heart, Liver, Thyroid

Publications for Pre-Eclampsia

Articles related to Pre-Eclampsia:

(show top 50) (show all 5797)
# Title Authors Year
1
Enhanced type I interferon gene signature in primary antiphospholipid syndrome: Association with earlier disease onset and preeclampsia. ( 30772492 )
2019
2
The Association Between Trimester-Specific Weight Gain and Severe Preeclampsia/Adverse Perinatal Outcome in Gestational Diabetes Mellitus Complicated by Preeclampsia: A Retrospective Case Study. ( 30838548 )
2019
3
Resveratrol promotes trophoblast invasion in pre-eclampsia by inducing epithelial-mesenchymal transition. ( 30710417 )
2019
4
Relationship between antithrombin activity and interval from diagnosis to delivery among pregnant women with early-onset pre-eclampsia. ( 30714139 )
2019
5
Correction: High-Resolution Genetic and Phenotypic Analysis of KIR2DL1 Alleles and Their Association with Pre-Eclampsia. ( 30728211 )
2019
6
The clinical enigma of the "Flea catcher" by Georges de La Tour: a pregnant sinner with pre-eclampsia or a hypothyroid girl? ( 30730039 )
2019
7
Increased biosynthesis and accumulation of cholesterol in maternal plasma, but not amniotic fluid in pre-eclampsia. ( 30733456 )
2019
8
Decreased Filamin b expression regulates trophoblastic cells invasion through ERK/MMP-9 pathway in pre-eclampsia. ( 30756369 )
2019
9
The ability of thromboelastography parameters to predict severe pre-eclampsia when measured during early pregnancy. ( 30763470 )
2019
10
Influence of NKG2C gene deletion and CCR5Δ32 in Pre-eclampsia-Approaching the effect of innate immune gene variants in pregnancy. ( 30786156 )
2019
11
Pre-eclampsia: pathogenesis, novel diagnostics and therapies. ( 30792480 )
2019
12
Relationships of serum placental growth factor and soluble fms-like tyrosine kinase-1 with fetal and uterine artery Doppler indices in pre-eclampsia. ( 30801711 )
2019
13
Evaluation of a simple risk score to predict preterm preeclampsia using maternal characteristics: a prospective cohort study. ( 30801934 )
2019
14
Aspirin and heparin for the prevention of pre-eclampsia: protocol for a systematic review and network meta-analysis. ( 30804037 )
2019
15
Increased expression and phosphorylation of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase isoforms in urinary exosomes in pre-eclampsia. ( 30819197 )
2019
16
Policy review on the management of pre-eclampsia and eclampsia by community health workers in Mozambique. ( 30819211 )
2019
17
Signalling of ERK1/2, P38MAPK and P90RSK in HIV-associated pre-eclampsia. ( 30821550 )
2019
18
Maternal serum lipid levels, oxidative stress and antioxidant activity in pre-eclampsia patients from Southwest India. ( 30825910 )
2019
19
Temporal and external validation of the fullPIERS model for the prediction of adverse maternal outcomes in women with pre-eclampsia. ( 30825926 )
2019
20
PARROT Ireland: Placental growth factor in Assessment of women with suspected pre-eclampsia to reduce maternal morbidity: a Stepped Wedge Cluster Randomised Control Trial Research Study Protocol. ( 30826791 )
2019
21
Human chorionic gonadotropin and the risk of pre-eclampsia: a prospective population-based cohort study. ( 30834627 )
2019
22
An integrated model of materno-foetal cardiac dysfunction in severe pre-eclampsia. ( 30839049 )
2019
23
Reactive Species Interactome Alterations in Oocyte Donation Pregnancies in the Absence and Presence of Pre-Eclampsia. ( 30845762 )
2019
24
Liver rupture in a 28-year-old primigravida with superimposed pre-eclampsia and hemolysis, elevated liver enzyme levels, and low platelet count syndrome. ( 30854740 )
2019
25
ELABELA, as a potential diagnostic biomarker of pre-eclampsia, regulates abnormally shallow placentation via APJ. ( 30860880 )
2019
26
lncRNA GHET1 has effects in development of pre-eclampsia. ( 30861585 )
2019
27
Ready for prime time - prediction of preterm pre-eclampsia. ( 30864241 )
2019
28
Association of Foxp3 and TGF-β1 Polymorphisms with Pre-Eclampsia Risk in Chinese Women. ( 30875252 )
2019
29
Perinatal outcomes of severe preeclampsia/eclampsia and associated factors among mothers admitted in Amhara Region referral hospitals, North West Ethiopia, 2018. ( 30876447 )
2019
30
Pre-eclampsia causing severe maternal morbidity - A national retrospective review of preventability and opportunities for improved care. ( 30883684 )
2019
31
Preeclampsia and risk of developing bronchopulmonary dysplasia in very preterm neonates. ( 30825928 )
2019
32
Validation of competing risks model in screening for pre-eclampsia in twin pregnancy by maternal factors. ( 30887621 )
2019
33
Upregulated long noncoding RNA Linc00261 in pre-eclampsia and its effect on trophoblast invasion and migration via regulating miR-558/TIMP4 signaling pathway. ( 30891826 )
2019
34
Placental growth factor in pre-eclampsia: friend or foe? ( 30904058 )
2019
35
Improving the knowledge of pregnant women using a pre-eclampsia app: A controlled before and after study. ( 30914185 )
2019
36
SEMA3B but Not CUL1 as Marker for Pre-Eclampsia Progression. ( 30914894 )
2019
37
Toll-like receptors signaling network in pre-eclampsia: An updated review. ( 30221394 )
2019
38
Pre-eclampsia/Eclampsia as a Risk Factor of Noninfectious Uveitis Among Postdelivery Women. ( 30316670 )
2019
39
ISUOG Practice Guidelines: role of ultrasound in screening for and follow-up of pre-eclampsia. ( 30320479 )
2019
40
Placental Elasticity as a New Non-invasive Predictive Marker of Pre-eclampsia. ( 30342781 )
2019
41
Maternal serum uric acid concentration and pregnancy outcomes in women with pre-eclampsia/eclampsia. ( 30353543 )
2019
42
Neutrophil-to-lymphocyte ratio and platelet indices in pre-eclampsia. ( 30362112 )
2019
43
Changes in calcium channel proteins according to magnesium sulfate administration in placentas from pregnancies with pre-eclampsia or fetal growth restriction. ( 30415221 )
2019
44
Pre-eclampsia onset and SPARC: A possible involvement in placenta development. ( 30426491 )
2019
45
A novel RNA interference approach to targeting sFLT1 in pre-eclampsia. ( 30514974 )
2019
46
Profound bilateral post-partum retinal circulation ischemia in two diabetic mothers with pre-eclampsia. ( 30519670 )
2019
47
Assessing the effect of dexmedetomidine in patients with pre-eclampsia. ( 30520788 )
2019
48
Hemodynamic relationship between ophthalmic artery and uterine artery in pre-eclampsia: pulse wave reflection and transmission might provide the missing link. ( 30604440 )
2019
49
A meta-analysis of tumor necrosis factor-α and FAS/FASL polymorphisms with risk of pre-eclampsia. ( 30606056 )
2019
50
Abducens nerve palsy as a sign of pre-eclampsia with severe features. ( 30626489 )
2019